Every plant in the process industry most likely has several control loops that do not perform well. Although there are many factors that may negatively affect control loop performance, a few of these ...
Whether improved glucose control with hybrid closed-loop therapy can preserve C-peptide secretion as compared with standard insulin therapy in persons with new-onset type 1 diabetes is unclear. A ...
Even patients with type 2 diabetes can benefit from using a fully closed-loop insulin delivery system, also known as an artificial pancreas, according to an open-label crossover trial. In the ...
Despite advances in care, attaining good glycemic outcomes in patients with type 1 diabetes remains challenging. The use of a closed-loop system (an “artificial pancreas”) that automates aspects of ...
A new software system that will let people with diabetes customize their treatment and automatically adjust their insulin levels was just approved for use by the Food and Drug Administration. It will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results